Alex Eapen

Director, R&D Scientific & Regulatory Affairs, North America,

All Sessions by Alex Eapen

Printer Friendly See Full Agenda

Day 1: Nov 17, 2020

Day 2: Nov 18, 2020

12:00 pm

12:00 pm

Case Study

GRAS – More Than Just Regulatory Slang

The FDA Generally Recognized As Safe (GRAS) process remains the mainstay by which ingredient manufacturers bring new innovative ingredients to the US market.  While the process can be a detailed, transparent and effective means for regulatory substantiation, it has received its share of criticism and can be difficult to understand for ingredient developers outside of the US. Gain insights to:

  • The perspective of a large ingredient supplier on how the GRAS process can be effectively leveraged
  • How this perspective can provide transparency for regulators,
  • A look at how this impacts CPG customers and consumers.

Understand GRAS as more than just regulatory slang.

Day 3: Nov 19, 2020